Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2092-6413
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers ; volume:51 ; number:5 ; day:9 ; month:5 ; year:2019 ; pages:1-10 ; date:5.2019
Experimental & molecular medicine ; 51, Heft 5 (9.5.2019), 1-10, 5.2019
- Urheber
-
Lee, Jinny Claire
Kim, Soo Jung
Hong, Seungpyo
Kim, YoungSoo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-019-0250-2
- URN
-
urn:nbn:de:101:1-2019101812133135707269
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jinny Claire
- Kim, Soo Jung
- Hong, Seungpyo
- Kim, YoungSoo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease